M&A Deal Summary

Bracco Diagnostics Acquires E-Z-EM

On April 2, 2008, Bracco Diagnostics acquired medical products company E-Z-EM for 186M USD

Acquisition Highlights
  • This is Bracco Diagnostics’ 1st transaction in the Medical Products sector.
  • This is Bracco Diagnostics’ largest (disclosed) transaction.
  • This is Bracco Diagnostics’ 1st transaction in the United States.
  • This is Bracco Diagnostics’ 1st transaction in New York.

M&A Deal Summary
Date 2008-04-02
Target E-Z-EM
Sector Medical Products
Buyer(s) Bracco Diagnostics
Deal Type Add-on Acquisition
Deal Value 186M USD
Advisor(s) RBC Capital Markets (Financial)

Target

E-Z-EM

Lake Success, New York, United States
E-Z-EM, Inc. is a manufacturer of contrast agents for gastrointestinal radiology.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bracco Diagnostics

Princeton, New Jersey, United States
Category Company
Founded 1994
Sector Medical Products
DESCRIPTION

Bracco Diagnostics, Inc. is a developer and marketer of imaging agents for use in X-ray/computed tomography, nuclear medicine, and magnetic resonance imaging.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (New York) 1 of 1
Country (United States) 1 of 1
Year (2008) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-02 Bracco - Healthcare Protective Products Division

United States

Bracco - Healthcare Protective Products Division includes the RSDL® (decontamination lotion) product that is cleared for marketing by the U.S. Food and Drug Administration (FDA) for removal or neutralization of chemical warfare agents from the skin, diversifies and broadens Emergent’s biodefense franchise into the chemical countermeasure market

Sell $26M
Mergr

Product

Company

Legal